Doximity (DOCS) EBITDA (2020 - 2026)

Doximity (DOCS) has 7 years of EBITDA data on file, last reported at $24.8 million in Q1 2026.

• On a quarterly basis, EBITDA fell 49.0% year-over-year to $24.8 million in Q1 2026; TTM through Mar 2026 was $214.9 million, a 5.65% decrease from a year earlier, with the FY2026 full-year figure at $214.9 million, down 5.65% from the prior year.
• EBITDA for Q1 2026 stood at $24.8 million, down from $71.9 million in the prior quarter.
• Over the last five years, EBITDA for DOCS reached as high as $79.9 million in Q4 2024 and fell as low as $21.7 million in Q2 2022.
• Historically, EBITDA has averaged $44.7 million across 5 years, with a median of $41.9 million in 2024.
• Across the five-year window, EBITDA surged 57.26% in 2024 and tumbled 49.0% in 2026, its largest moves.
• Year by year, EBITDA stood at $38.5 million in 2022, then surged by 52.14% to $58.6 million in 2023, then soared by 36.5% to $79.9 million in 2024, then slipped by 10.05% to $71.9 million in 2025, then sank by 65.47% to $24.8 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $24.8 million in Q1 2026, $71.9 million in Q4 2025, and $63.7 million in Q3 2025.